JPMorgan Chase & Co’s MiNK Therapeutics INKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89 | Sell |
12
-18
| -60% | -$134 | ﹤0.01% | 5965 |
|
|
2025
Q1 | $259 | Sell |
30
-3
| -9% | -$26 | ﹤0.01% | 5892 |
|
|
2024
Q4 | $227 | Buy |
33
+20
| +154% | +$138 | ﹤0.01% | 5845 |
|
|
2024
Q3 | $97 | Buy |
13
+2
| +18% | +$15 | ﹤0.01% | 5936 |
|
|
2024
Q2 | $102 | Hold |
11
| – | – | ﹤0.01% | 5862 |
|
|
2024
Q1 | $97 | Hold |
11
| – | – | ﹤0.01% | 5893 |
|
|
2023
Q4 | $115 | Hold |
11
| – | – | ﹤0.01% | 6067 |
|
|
2023
Q3 | $125 | Hold |
11
| – | – | ﹤0.01% | 5929 |
|
|
2023
Q2 | $225 | Buy |
+11
| New | +$225 | ﹤0.01% | 5715 |
|
|
2022
Q3 | – | Sell |
-25
| Closed | – | – | 5663 |
|
|
2022
Q2 | $0 | Sell |
25
-69
| -73% | – | ﹤0.01% | 5745 |
|
|
2022
Q1 | $2K | Buy |
+94
| New | +$2K | ﹤0.01% | 5591 |
|